全髋关节置换术破坏性出血与止血优化的专家意见调查
该结构化专家意见调查邀请14名擅长初次和翻修全髋关节置换术的关节外科医生,探讨「破坏性出血」这一复合概念是否与关节外科医生观点一致,并识别未来验证领域。受访者普遍支持将破坏性出血定义为改变诊疗的事件复合体,而非单纯数值失血量,但关于引流阈值和局部止血剂常规使用仍存分歧。
要点
- 破坏性出血被定义为改变诊疗的事件复合体,包括血红蛋白下降>3 g/dL、输血、引流延长、重返手术室、栓塞和再入院。
- 最常识别的出血危险因素为血小板减少和抗凝药使用(14/14),其次为凝血病和肝病(12/14)。
- 升级触发因素包括疑似动脉出血(14/14)、血肿扩大(13/14)、血流动力学不稳定(13/14)等。
核心结论
- 全髋关节置换术中的破坏性出血被视为由改变诊疗事件定义的复合概念,而非数值失血量指标。
- 该发现为探索性、假设生成性,识别了未来多学科前瞻性验证的候选领域。
研究设计与样本
- 结构化专家意见调查,发放给14名擅长初次和翻修全髋关节置换术的关节外科医生。
- 调查领域包括破坏性出血定义、危险因素、术中弥漫性渗血、术后引流、升级触发因素和局部止血剂使用。
- 采用描述性统计和精确分母报告,以至少70%同意率描述性识别高同意条目。
主要发现
- 所有受访者支持将破坏性出血描述为改变诊疗事件的复合体,包括症状性或改变管理的血红蛋白下降大于3 g/dL、输血、引流延长、重返手术室、栓塞和再入院。
- 最常识别的出血危险因素为血小板减少和抗凝药使用(14/14),其次为凝血病和肝病(12/14)。
- 升级触发因素包括疑似动脉出血(14/14)、血肿扩大(13/14)、血流动力学不稳定(13/14)、神经血管受损(13/14)和持续引流(12/14)。
- 仅4/14支持初次全髋关节置换术常规使用局部止血剂,7/14支持翻修全髋关节置换术选择性考虑使用。
- 关于时间定义和引流阈值仍存在分歧。
关键数值与推荐
- 破坏性出血复合定义包括症状性或改变管理的血红蛋白下降大于3 g/dL、输血、引流延长、重返手术室、栓塞和再入院(14/14支持)。
- 出血危险因素:血小板减少和抗凝药使用(14/14),凝血病和肝病(12/14)。
- 升级触发因素:疑似动脉出血(14/14)、血肿扩大(13/14)、血流动力学不稳定(13/14)、神经血管受损(13/14)、持续引流(12/14)。
- 局部止血剂:初次全髋关节置换术常规使用仅4/14支持,翻修全髋关节置换术选择性考虑7/14支持。
临床怎么用
- 临床可将破坏性出血作为改变诊疗事件的复合体进行识别和沟通,而非仅依赖数值失血量。
- 对血小板减少、抗凝药使用、凝血病和肝病患者应警惕破坏性出血风险。
- 疑似动脉出血、血肿扩大、血流动力学不稳定、神经血管受损或持续引流时应考虑升级处理。
- 局部止血剂在初次全髋关节置换术中不推荐常规使用,翻修术中可选择性考虑。
局限性
- 该调查为探索性、假设生成性研究,样本仅14名关节外科医生。
- 关于时间定义和引流阈值仍存在分歧,破坏性出血尚未标准化为临床实体。
- 结果需未来多学科前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite advances in perioperative blood management, disruptive bleeding after total hip arthroplasty (THA) remains clinically important, given associations with hematoma, wound complications, infection, reoperation, and resource utilization. The term "disruptive bleeding" has emerged from recent outcomes and health-economic work to describe bleeding-related events that alter care, but has not been standardized as a clinical entity in THA. This survey explored whether this construct aligns with arthroplasty surgeons' perspectives and identified domains for future validation. METHODS: A structured expert-opinion survey was distributed to 14 arthroplasty surgeons experienced in primary and revision THA. Domains included definitions of disruptive bleeding, risk factors, intraoperative diffuse oozing, postoperative drainage, escalation triggers, and topical hemostatic agent use. Responses included categorical selections, Likert-style ratings, and free-text comments. Descriptive statistics and exact denominators were reported. An agreement of at least 70% was used descriptively to identify high-agreement items. RESULTS: All respondents supported characterizing disruptive bleeding as a composite of care-altering events, including symptomatic or management-changing hemoglobin decline greater than three g/dL, transfusion, prolonged drainage, return to the operating room, embolization, and readmission. The most frequently identified bleeding risk factors were thrombocytopenia and anticoagulant use (n = 14 of 14), followed by coagulopathy and liver disease (n = 12 of 14). Escalation triggers included suspected arterial bleeding (n = 14 of 14), enlarging hematoma (n = 13 of 14), hemodynamic instability (n = 13 of 14), neurovascular compromise (n = 13 of 14), and persistent drainage (n = 12 of 14). Only four of 14 supported routine topical hemostatic agent use in primary THA, whereas seven of 14 supported selective consideration in revision THA. Disagreement remained regarding timing definitions and drainage thresholds. CONCLUSIONS: Disruptive bleeding in THA was viewed as a composite construct defined by care-altering events rather than numeric blood-loss measures. These findings are exploratory, hypothesis-generating, and identify candidate domains for future multidisciplinary and prospective validation.
引用
- Mont MA, Chen AF, Smitterberg CW, et al. Expert Perspectives on Disruptive Bleeding and Hemostasis Optimization in Primary and Revision Total Hip Arthroplasty: A Structured Expert-Opinion Survey. J Arthroplasty. 2026. PMID: 42869201. doi:10.1016/j.arth.2026.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。